What You Should Know:
- Sentara Healthcare, a health system in NC and VA, just partnered with Sensyne Health to drive clinical research with ethical AI.
- As part of a collaboration agreement, Sentara also becomes the first of several U.S. health systems that will partner with Sensyne to implement new clinical algorithms to support patients with CKD and CHF. The agreement will enable the ethical application of clinical AI research by Sensyne through analyzing Sentara’s patient dataset to
Read More
Kidney Disease
Cricket Health Secures $83.5M to Expand Value-Based Kidney Care Model to Health Plans
What You Should Know:
- Cricket Health, a San Francisco, CA-based provider of value-based kidney care with a clinically-proven approach to managing chronic kidney disease (CKD) and end-stage kidney disease (ESKD), today announced it has raised $83.5 million in Series B funding round led by Valtruis with a strategic investment from Blue Shield of California. The round also includes existing investors Oak HC/FT and Cigna Ventures, as well as K2 HealthVentures.
- This new funding will help
Read More
Will U.S. Healthcare Have The Same Success Rate With Chronic Kidney Disease As Native Americans?
For years, hypertension has dominated the healthcare field, afflicting 45 percent of all adult Americans, inducing a number of lethal complications in patients across the country. Another disease that has gained renown in the world of healthcare is diabetes, afflicting 10.5 percent of the U.S. population with its own complications.
Healthcare professionals have allocated untold assets in the form of time, money, and personnel to minimize the impact such diseases pose yet the relative
Read More
Q1 2021 Health IT/Digital Health PC/VE, M&A, IPOs/ SPACs Activity
The first quarter of 2021 has been one of investor optimism as the vaccine rollout continues ahead of expectations and economic activity begins to accelerate in response. Within the Health IT industry, the already strong investment and M&A trends seen in 2020 have only accelerated. Over the course of the quarter, we observed $7 billion in private equity and venture capital investment across 158 companies.
By comparison, Q1 of 2020 saw $3.2 billion and 127 investments. Health IT
Read More
Strive Health Raises $140M for Value-Based Kidney Care Platform
What You Should Know:
- Strive Health, a Denver-based provider of value-based kidney care today announced $140 million in Series B funding with Alphabet’s independent growth fund, CapitalG, as the lead investor. Strive has more than doubled its presence in regional markets and grown its employee base by more than 600% in the last year. This funding will further increase that momentum.
- Currently, there is $410 billion of unmanaged kidney disease
Read More
Why Patients, Not EHRs, Deserve our Undivided Attention
We cannot earn patients’ trust and respect if we are tethered to a computer in the exam room, navigating the EHR concurrent to a visit or otherwise in a hurry to finish so we can return to our office where data entry to the EHR awaits us.
______________________________________________________
I am a physician married to a physician, and for years, our evenings consisted of putting the kids to bed, then sitting next to each other, laptops open, finishing our charting. If you are a
Read More
AliveCor, AstraZeneca Partner to Screen for Blood Potassium Levels Via Electrocardiograms
What You Should Know:
- AliveCor, a digital AI-based personal technology provider, and AstraZeneca, a global leader in the biopharmaceutical space, are working together to create more informed disease management solutions across cardiovascular, renal, and metabolism therapeutic areas.
- The collaboration will focus on the development of AliveCor’s potassium detection technology through their Kardia-K AI platform, to screen for elevated levels of blood potassium via electrocardiograms.
Read More
Why CMS Will Lead the 2021 Kidney Care Revolution
After an unprecedented year, kidney care providers, including nephrologists, dialysis facilities, and care extenders are expecting 2021 to follow suit. We will see an overhaul in reimbursement and major industry shifts, partly led by CMS, that will require providers to advance their capabilities in a way that will usher in more widespread innovation. These new models encourage a shift in treatment approach that will deliver earlier interventions and better outcomes.
The following are
Read More
Frenova Begins Patient Enrollment to Build World’s Largest Genomics Registry for Kidney Disease
What You Should Know:
- Frenova Renal Research, a global division of Fresenius
Medical Care, announced today that it has started to enroll patients in its
new endeavor to build the world’s largest genomics registry targeting kidney
disease.
- The registry will be used to help advance understanding
of the genetic drivers of kidney disease and shape more precise, individualized
therapies.
Fresenius
Medical Care, the world’s leading provider of products and services for
people
Read More
DaVita & RenalytixAI Partner for Early Risk Identification to Help Slow Kidney Disease Progression
What You Should Know:
- RenalytixAI and DaVita announce a program partnership that
aims to slow kidney disease progression and improve outcomes for the nation’s
estimated 37 million adults with chronic kidney disease (CKD).
- This is the first clinical-grade program that delivers
advanced early-stage prognosis and risk stratification, combined with
actionable care management to the primary care level where the majority of
kidney disease patients are being seen.
- The program will use
Read More
